V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10443160 | 10033653 | 1.75 | 92 | Palliative (P) | 2016-09-18 | 2016-09-27 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100874456 |
| 10443177 | 10033654 | 1.55 | 56.9 | null | null | 2019-10-27 | PEMBROLIZUMAB | 02 | null | RITUXIMAB | 100435088 |
| 10443180 | 10033655 | 1.57 | 85.5 | Palliative (P) | 2019-08-08 | 2019-08-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101036782 |
| 10443192 | 10033656 | 1.78 | 0 | null | 2019-06-08 | 2019-06-15 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100638720 |
| 10443227 | 10033657 | 1.78 | 71 | Palliative (P) | 2020-09-25 | 2020-09-28 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100379458 |
| 10443257 | 10033658 | 1.69 | 86 | Adjuvant (A) | 2019-11-21 | 2019-11-28 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 100673548 |
| 10443262 | 10033659 | 1.67 | 72 | Palliative (P) | null | 2014-12-22 | Capecitabine | 02 | N | CAPECITABINE | 100569727 |
| 10443269 | 10033660 | 1.6 | 0 | Palliative (P) | 2017-12-05 | 2017-12-19 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101697019 |
| 10443291 | 10033661 | null | 90 | Palliative (P) | 2018-08-28 | 2018-09-20 | Rituximab | 02 | N | RITUXIMAB | 101564107 |
| 10443317 | 10033662 | 0 | 75 | Palliative (P) | 2021-10-11 | 2021-10-24 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101622664 |
| 10443339 | 10033663 | null | 74 | null | 2020-12-18 | 2021-03-23 | Rituximab | 02 | null | RITUXIMAB | 100743912 |
| 10443344 | 10033664 | 1.47 | 0 | 03 | 2019-05-30 | 2019-05-30 | IBRUTINIB | 02 | N | IBRUTINIB | 101665604 |
| 10443365 | 10033665 | 1.5 | 76.5 | 03 | 2018-04-05 | 2018-04-12 | CHOP R - 21 days | 02 | N | PEMBROLIZUMAB | 100579208 |
| 10443385 | 10033666 | 1.5 | 75.8 | 03 | 2016-12-20 | 2016-12-20 | IBRUTINIB | 02 | N | IBRUTINIB | 100614183 |
| 10443426 | 10033667 | 1.73 | 70 | Palliative (P) | 2018-02-22 | 2018-03-08 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101569697 |
| 10443500 | 10033668 | 1.6 | 0 | Palliative (P) | 2017-03-10 | 2017-03-24 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100763760 |
| 10443521 | 10033669 | 1.6 | 80.4 | Neo-adjuvant (N) | 2016-12-24 | 2017-01-11 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100849930 |
| 10443543 | 10033670 | 1.57 | 105 | Neo-adjuvant (N) | 2018-01-23 | 2018-02-05 | Docetaxel 75mg/m2 (21 day) | 02 | Y | DOCETAXEL | 100763402 |
| 10443550 | 10033671 | 1.61 | 71 | Neo-adjuvant (N) | 2017-11-11 | 2017-11-22 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100563075 |
| 10443560 | 10033672 | 1.68 | 85.5 | Palliative (P) | 2017-08-12 | 2017-08-12 | Capecitabine | 02 | null | CAPECITABINE | 100948981 |
| 10443570 | 10033673 | 1.61 | 78 | Curative (C) | 2019-12-17 | 2019-12-21 | Rituximab | 02 | N | RITUXIMAB | 100218038 |
| 10443589 | 10033674 | 1.62 | 72 | Palliative (P) | 2020-07-31 | 2020-08-10 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101861692 |
| 10443634 | 10033676 | 1.66 | 119 | Adjuvant (A) | 2021-05-04 | 2021-05-14 | Capecitabine | 02 | N | CAPECITABINE | 101383208 |
| 10443636 | 10033677 | 1.61 | 60.2 | Curative (C) | 2019-07-23 | 2019-08-01 | CHOP R - 21 days | 02 | null | PEMBROLIZUMAB | 101610922 |
| 10443642 | 10033678 | 1.57 | 81.8 | Neo-adjuvant (N) | 2018-12-06 | 2018-12-06 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 101059655 |
| 10443662 | 10033679 | 1.64 | 68.4 | null | 2020-08-06 | 2020-08-06 | Capecitabine | 02 | null | CAPECITABINE | 100905145 |
| 10443667 | 10033680 | 1.68 | 67.8 | null | 2020-01-19 | 2020-01-19 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100405658 |
| 10443691 | 10033681 | 1.66 | 73 | Palliative (P) | 2018-12-03 | 2018-12-03 | Capecitabine | N | N | CAPECITABINE | 100334348 |
| 10443697 | 10033682 | 0 | 100.8 | Adjuvant (A) | 2018-12-18 | 2018-12-18 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100750829 |
| 10443710 | 10033683 | 1.85 | 75 | null | 2016-09-21 | 2016-09-26 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101082057 |
| 10443712 | 10033684 | 1.55 | 92.3 | Adjuvant (A) | 2020-10-29 | 2020-11-08 | Capecitabine | 02 | N | CAPECITABINE | 101508066 |
| 10443734 | 10033685 | 1.69 | 59.8 | Adjuvant (A) | 2018-01-07 | 2018-01-09 | IBRUTINIB | 02 | N | IBRUTINIB | 101534279 |
| 10443742 | 10033686 | 1.68 | 101 | null | 2017-08-24 | 2017-08-24 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100365439 |
| 10443744 | 10033687 | null | null | null | 2021-12-12 | 2021-12-14 | IBRUTINIB | 02 | null | IBRUTINIB | 100860795 |
| 10443770 | 10033688 | 1.55 | 67.2 | null | 2022-04-09 | 2022-04-23 | Docetaxel | 02 | null | DOCETAXEL | 100288901 |
| 10443784 | 10033689 | null | 77 | Palliative (P) | 2013-05-07 | 2018-10-30 | IBRUTINIB | 02 | N | IBRUTINIB | 100984473 |
| 10443791 | 10033690 | 1.62 | 73.5 | null | 2019-12-02 | 2019-12-05 | Capecitabine | 02 | null | CAPECITABINE | 100845468 |
| 10443797 | 10033691 | 1.68 | 67.8 | Curative (C) | 2019-10-17 | 2019-10-31 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101177465 |
| 10443813 | 10033692 | 1.75 | 57 | Palliative (P) | 2018-03-08 | 2018-03-12 | Capecitabine | N | N | CAPECITABINE | 100137048 |
| 10443816 | 10033693 | 1.64 | 79.2 | Palliative (P) | 2019-03-24 | 2019-04-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101471907 |
| 10443821 | 10033694 | 1.7 | 88 | Disease modification (D) | 2017-12-02 | 2017-12-02 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101217525 |
| 10443854 | 10033695 | 1.73 | 0 | Palliative (P) | 2017-12-23 | 2018-01-10 | CHOP R - 21 days | 02 | N | PEMBROLIZUMAB | 101256455 |
| 10443890 | 10033696 | 1.79 | 59.7 | Curative (C) | 2019-12-06 | 2019-12-24 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101464959 |
| 10443891 | 10033697 | 1.8 | 88.2 | Palliative (P) | 2016-12-23 | 2020-05-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101660898 |
| 10443894 | 10033698 | null | 89.3 | Adjuvant (A) | 2017-05-18 | 2017-06-01 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100180203 |
| 10443915 | 10033699 | null | 102.9 | Palliative (P) | 2017-02-26 | 2017-03-03 | Rituximab | 02 | N | RITUXIMAB | 101825855 |
| 10443932 | 10033700 | null | 76 | Palliative (P) | 2019-06-17 | 2019-06-17 | IBRUTINIB | 02 | N | IBRUTINIB | 100186707 |
| 10443934 | 10033701 | null | 96.6 | Palliative (P) | 2016-11-21 | 2016-11-21 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101396620 |
| 10443944 | 10033702 | 1.75 | 77 | null | 2021-03-05 | 2021-03-11 | Capecitabine | 02 | null | CAPECITABINE | 100284209 |
| 10443952 | 10033703 | 1.82 | 104.9 | null | 2017-11-02 | 2017-11-23 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100088043 |